R. Minso

Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test

T. Welte, F. Stanke, B. Tümmler, 2020, BMJ open respiratory research.

Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseases

O. Sommerburg, C. Stolpe, M. Kopp, 2020, ERJ Open Research.

Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy

T. Welte, F. Stanke, B. Tümmler, 2023, Frontiers in Pharmacology.

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles

O. Sommerburg, B. Tümmler, M. Mall, 2021, American Journal of Respiratory and Critical Care Medicine.

The Cystic Fibrosis Upper and Lower Airway Metagenome

J. Mainz, J. Klockgether, B. Tümmler, 2023, Microbiology spectrum.

Functional analysis of the p.[Arg74Trp;Val201Met;Asp1270Asn]/p.Phe508del CFTR mutation genotype in human native colon

F. Stanke, B. Tümmler, J. Reiss, 2019, Molecular genetics & genomic medicine.

Differential effects of ELX/TEZ/IVA on organ-specific CFTR function in two patients with the rare CFTR splice mutations c.273+1G>A and c.165-2A>G

B. Tümmler, G. Hansen, M. Nietert, 2023, Frontiers in Pharmacology.

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles.

O. Sommerburg, B. Tümmler, M. Mall, 2021, American journal of respiratory and critical care medicine.

Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity

B. Tümmler, G. Hansen, S. Junge, 2023, Frontiers in pharmacology.